1.Beyond blood safety.
Annals of the Academy of Medicine, Singapore 2010;39(6):422-423
2.When less is more: can we abandon prophylactic platelet transfusion in Dengue fever?
Changa KURUKULARATNE ; Frederico DIMATATAC ; Diana Lt TEO ; David C LYE ; Yee Sin LEO
Annals of the Academy of Medicine, Singapore 2011;40(12):539-545
Dengue fever (DF) has several hematological manifestations including thrombocytopenia and increased bleeding risk. Prophylactic platelet transfusion-in the absence of major bleeding-is utilized in DF with thrombocytopenia with the intention of preventing hemorrhagic complications. However, prophylactic platelet transfusion in DF is neither standardized nor supported by clinical evidence. We conclude that risks, costs and poor resource utilization associated with prophylactic platelet transfusion in DF far outweigh any potential hematological benefit, and as such, should not constitute routine clinical practice.
Dengue
;
complications
;
therapy
;
Hemorrhage
;
etiology
;
prevention & control
;
Humans
;
Platelet Transfusion
;
adverse effects
;
economics
;
Thrombocytopenia
;
etiology
;
prevention & control
3.Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations.
Benjy Yi-Min SOH ; Rajneesh KUMAR ; Victoria Sze-Min EKSTROM ; Clement Yi-Hao LIN ; Sobhana THANGARAJU ; Hwee Huang TAN ; Kwai Peng CHAN ; Lina Hui Lin CHOONG ; Diana TEO ; Wan Cheng CHOW
Singapore medical journal 2019;60(1):34-39
INTRODUCTION:
To study the prevalence of hepatitis C virus (HCV) infection in blood donor (BD), haemodialysis (HD) and intravenous drug user (IVDU) populations in Singapore and assess the IL28B polymorphism if HCV positive.
METHODS:
The BD population were healthy volunteers, the HD population were patients who were on haemodialysis for at least six months of follow-up between January 2009 and December 2014. IVDU population was from inmates at halfway houses who consented.
RESULTS:
Between 2011 and 2014, of 161,658 individuals who underwent screening prior to blood donation, 95 (0.059%) were positive for HCV. Of the 42 sera available, common genotypes (GTs) were GT-3 (47.6%) and GT-1 (31.0%). Of 1,575 HD patients, 2.2% were anti-HCV positive. The HCV GT distribution was HCV GT-1 (32.4%), HCV GT-3 (20.5%) and GT-6 (8.8%). 83 halfway house inmates were screened. Of the 47 IVDUs, 36.2% were anti-HCV positive with predominant GT-3 (%). IL28B polymorphism was noted to be CC predominantly 85.3%.
CONCLUSION
Prevalence of HCV infection has decreased in both the BD and HD populations. However, it remains high in the IVDU population. GT-1 remains the most common in the HD population; however, GT-3 infection is now more common among the BD population in Singapore. IL28B - CC is the predominant variant among the HCV-infected individuals in Singapore.
Acute Kidney Injury
;
blood
;
complications
;
Adult
;
Alleles
;
Blood Donors
;
Female
;
Genotype
;
Hepatitis C
;
epidemiology
;
Humans
;
Interleukins
;
genetics
;
Male
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Prevalence
;
Renal Dialysis
;
Singapore
;
epidemiology
;
Substance Abuse, Intravenous
;
blood
;
epidemiology
;
Young Adult
4.Authors' reply.
Benjy Yi-Min SOH ; Rajneesh KUMAR ; Victoria Sze-Min EKSTROM ; Clement Yi-Hao LIN ; Sobhana D/O THANGARAJU ; Hwee Huang TAN ; Kwai Peng CHAN ; Lina Hui Lin CHOONG ; Diana TEO ; Wan Cheng CHOW
Singapore medical journal 2019;60(6):323-323
Blood Donors
;
Genotype
;
Hepacivirus
;
Humans
;
Interferons
;
Prevalence